PFIZER
Back to Balance Sheet
|
PFIZER Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹156 Cr | ₹176 Cr | ₹437 Cr | ₹548 Cr | ₹467 Cr |
What is the latest Contingent Liabilities ratio of PFIZER ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹156 Cr |
| Mar2024 | ₹176 Cr |
| Mar2023 | ₹437 Cr |
| Mar2022 | ₹548 Cr |
| Mar2021 | ₹467 Cr |
How is Contingent Liabilities of PFIZER Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹156 Cr | -11.64 | |
| Mar2024 | ₹176 Cr | -59.62 | |
| Mar2023 | ₹437 Cr | -20.37 | |
| Mar2022 | ₹548 Cr | 17.47 | |
| Mar2021 | ₹467 Cr | - | |
Compare Contingent Liabilities of peers of PFIZER
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PFIZER | ₹21,019.7 Cr | -1.7% | -4.5% | -10.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,096.0 Cr | -2.4% | 3% | 9.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,807.0 Cr | -3.3% | 3.5% | 4.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,718.0 Cr | -2% | 5% | 43.1% | Stock Analytics | |
| CIPLA | ₹112,971.0 Cr | -0% | 6.9% | -4.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,752.0 Cr | -0.3% | -3.8% | 7.3% | Stock Analytics | |
PFIZER Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PFIZER | -1.7% |
-4.5% |
-10.2% |
| SENSEX | -0.5% |
-3.3% |
-7.6% |
You may also like the below Video Courses